Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...
Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback